This document provides guidance to industry and other stakeholders (e.g., consumer interest groups, academia, other regulatory groups) on FDA’s current thinking concerning what constitutes Good Manufacturing Practices (GMPs) for cosmetics. It is intended to assist industry and other stakeholders in identifying the standards and issues that can affect the quality of cosmetic products.
See also Public Meeting: Good Manufacturing Practices for Cosmetic Products. FDA intends to withdraw or revise and reissue this draft guidance as appropriate, based on the GMP rulemaking required by the Modernization of Cosmetics Regulation Act of 2022.
